161 results
Page 8 of 9
424B3
nbxub
4 Mar 14
Prospectus supplement
12:00am
424B1
uxv8ve vcej
31 Jan 14
Prospectus with pricing info
12:00am
8-K
5arj gyq6x
7 Jan 14
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
EX-14.1
w7eku0 acospx69yci
7 Jan 14
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
424B3
ojxbfp389uahufgvphy
19 Dec 13
Prospectus supplement
12:00am
8-K
EX-99.1
kt9yqe da3
9 Dec 13
Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia
12:00am
8-K
sfv8n028itgnare
9 Dec 13
Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia
12:00am
8-K/A
EX-10.1.1
ymao7qy6k5366
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
fqak knbz1fuukp2f
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.2
0s9og763ulgtanh
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
S-1
whz4exylv klnmp8sv
18 Sep 13
IPO registration
12:00am
8-K
EX-10.1.1
5s60nr
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-10.2
g1fwk
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
zrktli
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-99.3
bljqm687q0
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-2.1
dcm29
29 Aug 13
Entry into a Material Definitive Agreement
12:00am
10-Q
yeqoluzfykoy8c2gi77m
14 Aug 13
Quarterly report
12:00am
10-K
EX-14.1
i0jqrt5 vlba
16 Jul 13
Annual report
12:00am